Dianet Dialysis Center/Division of Nephrology, Department of Medicine, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, AZ, 1105, Amsterdam, the Netherlands.
Department of Medicine, Division of Nephrology, Amsterdam UMC location University of Amsterdam, Internal Medicine and Nephrology, Meibergdreef 9, AZ, 1105, Amsterdam, the Netherlands.
BMC Nephrol. 2022 Aug 23;23(1):292. doi: 10.1186/s12882-022-02869-6.
Telehealth could potentially increase independency and autonomy of patients treated with peritoneal dialysis (PD). Moreover, it might improve clinical and economic outcomes. The demand for telehealth modalities accelerated significantly in the recent COVID-19 pandemic. We evaluated current literature on the impact of telehealth interventions added to PD-care on quality of life (QoL), clinical outcomes and cost-effectiveness.
An electronic search was performed in Embase, PubMed and the Cochrane Library in order to find studies investigating associations between telehealth interventions and: i. QoL, including patient satisfaction; ii. Standardized Outcomes in Nephrology (SONG)-PD clinical outcomes: PD-related infections, mortality, cardiovascular disease and transfer to hemodialysis (HD); iii. Cost-effectiveness. Studies investigating hospitalizations and healthcare resource utilization were also included as secondary outcomes. Due to the heterogeneity of studies, a meta-analysis could not be performed.
Sixteen reports (N = 10,373) were included. Studies varied in terms of: sample size; design; risk of bias, telehealth-intervention and duration; follow-up time; outcomes and assessment tools. Remote patient monitoring (RPM) was the most frequently studied intervention (11 reports; N = 4982). Telehealth interventions added to PD-care, and RPM in particular, might reduce transfer to HD, hospitalization rate and length, as well as the number of in-person visits. It may also improve patient satisfaction.
There is a need for adequately powered prospective studies to determine which telehealth-modalities might confer clinical and economic benefit to the PD-community.
远程医疗有可能提高腹膜透析(PD)患者的独立性和自主性。此外,它可能改善临床和经济结果。在最近的 COVID-19 大流行期间,对远程医疗模式的需求急剧增加。我们评估了关于将远程医疗干预措施添加到 PD 护理中对生活质量(QoL)、临床结果和成本效益的影响的现有文献。
在 Embase、PubMed 和 Cochrane 图书馆中进行了电子搜索,以查找研究远程医疗干预措施与以下方面之间关联的研究:i. QoL,包括患者满意度;ii. 肾脏病标准化结局(SONG)-PD 临床结局:与 PD 相关的感染、死亡率、心血管疾病和转至血液透析(HD);iii. 成本效益。还包括调查住院和医疗资源利用的研究作为次要结果。由于研究的异质性,无法进行荟萃分析。
纳入了 16 份报告(N=10373)。研究在样本量、设计、偏倚风险、远程医疗干预措施和持续时间、随访时间、结局和评估工具等方面存在差异。远程患者监测(RPM)是研究最多的干预措施(11 份报告;N=4982)。将远程医疗干预措施添加到 PD 护理中,特别是 RPM,可能会降低转至 HD、住院率和住院时间以及面对面就诊次数。它还可能提高患者满意度。
需要进行充分的前瞻性研究,以确定哪些远程医疗模式可能会为 PD 社区带来临床和经济效益。